DHEA-S is the sulfated form of dehydroepiandrosterone, produced primarily by the adrenal glands. It serves as a precursor that the body converts into testosterone and estrogen as needed. Levels peak in the mid-20s and decline steadily with age. By 70, levels are typically 10-20% of peak.
DHEA-S is one of the most reliably age-associated biomarkers and is commonly tracked as a longevity and adrenal-function indicator. Low levels correlate with accelerated aging, reduced bone density, and impaired immune function. Both sexes benefit from optimal levels, though women are more often supplemented because their baseline production is lower and menopause drops levels further. Optimal ranges are age-stratified. What's "normal" for a 25-year-old is very different from a 65-year-old.
Optimal DHEA-S: 250-450 µg/dL.
Typically re-tested every 12 weeks.
Because the sulfated form clears slowly, a single draw gives a steady picture of adrenal androgen production rather than a snapshot of one moment. That is why clinicians and lab panels lean on DHEA-S rather than DHEA itself when they want a stable read. This page covers what the marker is, typical and optimal ranges, and what high and low DHEA-S levels may reflect.
DHEA-S is dehydroepiandrosterone sulfate, the sulfated storage form of the adrenal androgen precursor DHEA, produced mainly in the zona reticularis of the adrenal cortex.
The mechanism is worth understanding because it explains why this marker behaves differently from most hormones. DHEA is made from pregnenolone along the adrenal steroid pathway, then a sulfotransferase enzyme attaches a sulfate group. That change makes the molecule water soluble, biologically quiet and slow to clear, so it accumulates in the blood at concentrations far above most other steroids. Research on steroid conjugates describes these sulfated forms as a circulating reservoir that tissues can draw on and convert back into active hormone locally[1].
That reservoir matters because peripheral tissues, including skin, hair follicles, fat and the reproductive tract, carry the enzymes to turn DHEA into testosterone and, downstream, into estrogens. DHEA-S itself does not bind androgen receptors in any meaningful way. It is the raw material, not the finished product.
Adrenal production of DHEA-S switches on in childhood during adrenarche, the maturation of the adrenal androgen zone that drives the first appearance of body odour, oily skin and pubic hair, a process reviewed in detail in the endocrine literature[2]. Output peaks in early adulthood and then declines slowly and steadily across the decades. Production is driven largely by pituitary ACTH, not by the LH and FSH signals that govern the ovaries and testes, which is exactly why the marker is used to ask whether androgen activity is coming from the adrenals or the gonads.
It matters because DHEA-S is the clearest single measure of adrenal androgen reserve, and that reserve changes with age, illness and hormonal transitions.
The first reason is localisation. When androgen-related signs appear, DHEA-S helps separate an adrenal source from an ovarian or testicular one, because the adrenal gland is effectively the only meaningful producer of the sulfated form.
The second reason is the age curve. Levels fall progressively through adult life, and population research has examined whether lower DHEA-S tracks with worse outcomes.[3] A review of DHEA and mortality concluded that the association is real in several cohorts but that its nature remains unsettled, with low levels plausibly acting as a marker of poor health rather than a cause of it[3]. That distinction is the whole argument, and it is not closed. Treat low DHEA-S as a signal worth understanding, not as a verdict.
The third reason is relevant after menopause. Once ovarian output falls, adrenal precursors become a major contributor to the androgens and estrogens produced inside peripheral tissues, which is why DHEA-S draws attention in postmenopausal hormone research[4].
There is also a training angle. A systematic review of exercise in older adults reported that structured training is associated with shifts in the balance of anabolic and catabolic hormones, including DHEA-S and cortisol, although findings varied across study designs[5].
Most laboratories report DHEA-S in micrograms per decilitre, and a commonly used adult reference span runs from roughly 80 to 560 µg/dL, with FitScript's optimal target sitting inside it.
| Marker | Units | Standard lab reference range | FitScript optimal range |
|---|---|---|---|
| DHEA-S | µg/dL | 80 to 560 | 250 to 450 |
A German population study (KORA) measured DHEA-S by LC-MS/MS in 519 healthy adults aged 32 to 90.[13] In men the range fell steadily with each age decade, and postmenopausal women ran well below premenopausal women.[13]
| Sex | Age | Reference range (nmol/L) |
|---|---|---|
| Men | 30 to 39 | 2782 to 11864 |
| Men | 40 to 49 | 1230 to 8987 |
| Men | 50 to 59 | 986 to 8867 |
| Men | 60 to 90 | 502 to 6678 |
| Women | Premenopausal (32 to 54) | 1023 to 7362 |
| Women | Postmenopausal (50 to 90) | 277 to 6488 |
Ranges are the 2.5th to 97.5th percentiles, split by age decade in men and by menopausal status in women, and are reported in nmol/L (the paper's unit, not converted to µg/dL). Your own lab's printed range is the one to read your result against, since values depend on the assay used.
The standard column is a typical lab reference range, meaning the span that covers most apparently healthy adults tested at that laboratory. Reference ranges vary by lab, age and sex, and most labs publish separate bands for men and women and for each age decade, so always read your result against the range printed on your own report. The FitScript column is an optimization target, not a diagnostic cut-off, and a value outside it is not a diagnosis of anything.
Two practical notes. Age matters more for this marker than for almost any other hormone, so a value that looks low against a young adult band may be entirely ordinary for someone three decades older. And the gap between the standard range and a narrower optimal target is where most of the useful conversation happens, because a result can sit technically within range while still being lower than you would choose for your age.
An elevated DHEA-S result means the adrenal glands are releasing more androgen precursor than the reference range expects, which points toward an adrenal source of androgen activity rather than to any single condition.
Symptoms people report. Women more often notice acne that persists past adolescence, oilier skin, coarser facial or body hair, thinning at the scalp, and irregular or missed cycles. Men frequently report nothing at all, because a modest rise in adrenal precursor adds little on top of testicular testosterone. In children, early body odour and pubic hair can reflect adrenarche arriving ahead of schedule[2].
Common causes. Polycystic ovary syndrome is a frequent context, and a meaningful subset of people with PCOS show an adrenal component to their androgen excess alongside the ovarian one[6]. Nonclassic congenital adrenal hyperplasia, a partial enzyme difference in the adrenal steroid pathway, is another recognised cause. Supplemental DHEA raises the measured value directly. An adrenal mass found on imaging may also be hormonally active, and the workup of adrenal incidentalomas routinely includes androgen measurement[7]. Reviews of the biochemical criteria for hyperandrogenism stress that no single androgen value settles the question and that results are interpreted alongside the clinical picture[8].
Long-term health impact. Mild elevations are common and often sit alongside insulin resistance or weight-related metabolic change rather than any adrenal pathology. A markedly high value, or one that climbs quickly on repeat testing, is a different situation and is worth discussing with a clinician promptly, because the evaluation of a possible adrenal source is time sensitive. Observation, then inference, then a conversation with a clinician, in that order.
A low DHEA-S result means adrenal androgen output is below the expected band for your age and sex, which most often reflects normal ageing but can also reflect reduced adrenal or pituitary signalling.
Symptoms people report. Low energy, flat mood, reduced libido and a general sense of diminished wellbeing come up frequently, and all of them are non-specific. None of these confirms anything on its own, which is exactly why the marker is read in context rather than alone.
Common causes. Age is the dominant one. Beyond that, adrenal insufficiency reduces adrenal steroid output broadly, and a recent review describes how the condition is identified and monitored in adults[9]. Because production depends on pituitary ACTH, a deficiency of that signal also lowers the marker, and corticotroph deficiency is recognised as a cause of reduced adrenal androgen production[10]. Chronic illness, significant undereating and poor sleep are also associated with lower levels, though the direction of cause is rarely clean.
Long-term health impact. In postmenopausal women, low adrenal precursor availability limits the raw material for tissue-level androgen and estrogen production[4]. Across populations, lower levels have been linked with higher mortality, but the literature cautions that illness itself lowers the marker, so the association may run in both directions[3]. A very low result, particularly alongside fatigue, low blood pressure, salt craving or unexplained weight loss, is worth raising with a clinician promptly rather than monitoring alone.
Several things shift DHEA-S independently of your underlying adrenal health, and knowing them prevents over-reading a single number.
Testing conditions. The sulfated form has a long circulating half-life, so it varies far less across the day than cortisol or unsulfated DHEA. Timing is therefore less critical than for most hormones, though a morning draw taken under consistent conditions makes results easier to compare over time. Acute illness, recent surgery and severe sleep loss can all depress a reading temporarily.
Supplements and medications. Over-the-counter DHEA supplements raise the measured value, sometimes substantially, and should always be declared before testing. High-dose biotin can interfere with certain immunoassays and distort results, so pausing it before testing is a common lab instruction. Any prescription therapy that touches hormones, including testosterone or women's hormone therapy, is something a licensed provider evaluates for appropriateness after reviewing your labs and history.
Habits. Research on exercise in older adults suggests structured training is associated with a more favourable anabolic to catabolic hormone balance, though effects differ by programme and population[5]. Dietary change has been studied mostly in the PCOS setting, where a randomised trial comparing moderate-carbohydrate and ketogenic approaches in women with overweight or obesity and PCOS reported changes in metabolic and hormonal measures[11]. Vitamin D status has also been examined in the same population, with a randomised trial assessing supplementation against markers related to fertility[12]. These levers may nudge the broader hormonal picture rather than target this one marker, and none of them replaces a clinical evaluation.
DHEA-S is measured from a standard venous blood draw and appears on hormone-focused lab panels alongside the other adrenal and gonadal markers it is read against.
FitScript is built around repeat testing rather than a single snapshot, with 150+ biomarkers tested per year, so a marker like this one can be followed as a trend across the year instead of judged on one draw. That matters here specifically, because the clinical meaning of a value depends heavily on its direction over time and on the markers measured beside it.
Results are interpreted by Atlas, FitScript's AI health advisor, which reads the panel as a whole and writes your FitScript, the personalised output generated from your own biology. Atlas describes what a value shows, what it may reflect, and what is worth raising with a clinician. It does not name a diagnosis, and neither should any number on a lab report. Where a prescription therapy is on the table, a licensed provider reviews your results and history and decides whether it is appropriate for you.
DHEA-S is close to uninterpretable in isolation, because its meaning depends on what the rest of the steroid pathway is doing.
These markers are typically measured together on Hormone Panel for men and Hormone Panel for women rather than ordered one at a time.
DHEA-S is the stable, sulfated reservoir of adrenal androgen precursor, it peaks in early adulthood and declines for the rest of life, and it is read as a pattern across related markers rather than as a standalone verdict. A high value points toward an adrenal androgen source and deserves context. A low value most often reflects age, sometimes reflects reduced adrenal or pituitary signalling, and is never ignored. Marked results in either direction are worth discussing with a clinician promptly.
This page is educational and is not medical advice. Discuss your own results, and any treatment decision, with a clinician or licensed provider who has reviewed your full history.
It measures the amount of dehydroepiandrosterone sulfate circulating in your blood, which is the sulfated storage form of an androgen precursor made almost entirely by the adrenal glands. Because the sulfated form clears slowly, the result reflects sustained adrenal androgen output rather than a momentary spike.
They are closely related but not identical. DHEA is the active precursor, and DHEA-S is the same molecule with a sulfate group attached, which makes it water soluble, biologically quiet and long lasting in the blood. Labs usually measure the sulfated form because it is far more stable across the day.
Fasting is not usually required for this marker specifically, because it varies little across the day. It is often drawn as part of a wider panel that does require fasting, so follow the instructions on your own lab requisition. Declare any DHEA supplement or high-dose biotin beforehand, since both can shift results.
Common contexts include an adrenal component of polycystic ovary syndrome, nonclassic congenital adrenal hyperplasia, supplemental DHEA use, early adrenarche in children, and occasionally a hormonally active adrenal mass. A single elevated value identifies a pattern, not a diagnosis, and is interpreted alongside symptoms and the rest of the hormone panel.
Age is the most common reason, since adrenal androgen output declines steadily through adult life. Reduced pituitary ACTH signalling, adrenal insufficiency, chronic illness and significant undereating are also associated with lower values. A very low result alongside fatigue or unexplained weight loss is worth raising with a clinician promptly.
Yes. Production rises during adrenarche in childhood, peaks in early adulthood and then declines gradually across the following decades. This is why age-specific reference bands matter so much for this marker. A value that looks low against a young adult range may be entirely ordinary for an older adult.
The standard range of roughly 80 to 560 µg/dL is a typical lab reference span covering most apparently healthy adults, and it varies by lab, age and sex. FitScript's optimal range of 250 to 450 µg/dL is an optimization target used for tracking, not a diagnostic cut-off, so sitting outside it does not indicate a condition.
It can be part of the explanation. Because tissues convert the precursor into active androgens locally, elevated levels are associated with acne, oily skin, coarser facial or body hair and scalp thinning, particularly in women. Those signs have several possible drivers, so a clinician reads the value alongside testosterone, SHBG and the clinical picture.
A markedly elevated value, a value rising quickly on repeat testing, or a very low value accompanied by fatigue, low blood pressure, salt craving or unexplained weight loss all warrant a prompt conversation. No abnormal result should be ignored, and no result should be interpreted as a diagnosis without clinical evaluation.